期刊文献+

临床细菌耐药分析及耐药酶的检测 被引量:4

Analysis of Clinical Bacteria Drug Resistance and Detection of Drug Resistance Enzyme
下载PDF
导出
摘要 目的监测本地区2000-2006年临床细菌的构成分布及耐药性,并检测其是否产耐甲氧西林金黄色葡萄球菌(MRS)、耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)、超广谱β-内酰胺酶(ESBLs)。方法MicroSCANAUTOSCAN4半自动鉴定药敏仪对送检标本进行菌种鉴定和药敏试验,琼脂筛选法检测MRS、MRCNS,K-B纸片扩散法检测ESBLs,比较产酶株与非产酶株对抗菌药物的活性。结果8448份临床标本检出各种细菌2436株,检出率为28.84%,种类以革兰阴性杆菌为主,占45.26%,最常检出的细菌依次为大肠埃希菌、CNS(-)葡萄球菌、肺炎克雷伯菌、铜绿假单胞菌、肠球菌属、金黄色葡萄球菌,MRS、MRCNS、ESBLs检出率高,耐药性强,耐药谱广。结论临床分离菌以条件致病菌为主,耐药株分离高,建议临床医生根据药敏试验合理用药,以减少耐药菌株产生。 Objective To monitor the local clinical bacteria distribution and their drug - resistance, and to detect MRS, MRCNS, and ESBLS in these clinical isolates. Methods Antimicrobial sensitivities were determined by Dade MicroSCAN AUTOSCAN4. MRS and MRCNS were detected with agar filtration method. ESBLs were detected with K - B susceptibility method. Results Among the 2,436 (28.84 % ) strains of germs isolated from 8,448 clinical samples, Gram - negative bacilli were the dominant pathogens (4.5.26 % ). The pathogenic bacteria were Escherichia colia, and followed by Coagulase - negative staphylococous, Klelosiella pneumoniae, Pseudomonase aeruginosa, enterococcus and staphylococous. MRS, MRC- NS, and ESBLs showed high positive testing rate, and also had strong and wide drug- resistance spectrum. Conclusions Conditional pathogens are the major clinical bacteria and the drug - resistance is higher, therefore the clinicians should choose the suitable antibiotics according to the results of antibiotic susceptibility test for reducing the drug- resistance strain.
出处 《实用预防医学》 CAS 2007年第6期1729-1731,共3页 Practical Preventive Medicine
关键词 细菌 多重耐药 抗生素 Bacteria Multiple drug resistance Antibiotic
  • 相关文献

参考文献8

二级参考文献28

  • 1李厚敏,刘伟,李若瑜.美国临床实验室标准化委员会2003年版产孢丝状真菌药敏试验方案简介[J].中华检验医学杂志,2005,28(1):121-123. 被引量:26
  • 2[1]Pinho MG, Filipe SR, Lencastre H, et al. Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus[J]. J Bacteriol, 2001, 183(22): 6525-6531. 被引量:1
  • 3[2]Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of microorganisms in hospitals[J]. JAMA, 1996, 275(3): 234. 被引量:1
  • 4[5]Krcmery V, Sykora P, Trupl J, et al. Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer referral center[J]. J Chemother, 2001, 13(2): 133-142. 被引量:1
  • 5[6]Rojas H, Fernandez LN, Espino HM, et al. Patterns of drug resistance in Staphylococcus aureus from human clinical isolates[J]. Rev Cubana Med Trop, 2001, 53(1): 53-58. 被引量:1
  • 6叶任高.内科学[M](第5版)[M].北京:人民卫生出版社,2001.824. 被引量:267
  • 7张秀珍.当代细菌检验与临床[M].北京:人民卫生出版社,1990.. 被引量:5
  • 8JactodyGA,Han P.Detection of extended-spectrum beta-lactamases in clinical isolates of klebsiella pneumoniac and Escherichia coil[J].clin Microbiol,1996,34:908-911. 被引量:1
  • 9YagY,Li Vermone DM interation of meropenem with deas betalitamaies[J].Antimicrob chemother,1989,24(suppla):207. 被引量:1
  • 10Bushk, Jasoby GA, Medeiros AA.Afunctional classification scheme for beta-lactamases and its correlation with mdecular structure[J].Antimicrob Agents Chemother,1995,39:111-1233. 被引量:1

共引文献575

同被引文献31

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部